期刊文献+

hIL-1Ra基因的克隆及在原核细胞中的表达 被引量:1

Cloning of hIL-1Ra gene and its expression in E.coli
下载PDF
导出
摘要 目的 :克隆hIL 1Ra基因并在大肠杆菌中高效表达。方法 :从人外周血中分离白细胞并提取其总RNA。用RT PCR获得hIL 1RacDNA ,克隆入pBV2 2 0表达载体进行诱导表达。对表达产物进行复性和纯化。结果 :成功地构建了pBV2 2 0 IL 1Ra表达载体 ,并在大肠杆菌中获得高效表达 ,表达量占全菌的 4 0 %。对表达产物进行分离纯化及活性分析表明 ,获得纯度大于98%的样品。该样品具有明显抑制IL 1刺激EL 4细胞分泌IL 2的作用。结论 :在大肠杆菌中成功地表达有活性的hIL 1Ra基因 ,为进一步的开发利用奠定了实验基础。 AIM: To clone human IL-1Ra gene and express it in E.coli. METHODS: Human IL-1Ra cDNA was obtained by RT-PCR with the the total RNA extracted from human peripheral blood leucocytes as template. The cDNA was cloned into pBV220 vector and expressed. The expressed product was renatured and purified. Separation, purification and bioactivity analysis of the expressed products were performed. RESULTS: IL-1Ra gene was successfully expressed in E.coli and the expression level reached to about 40% of total bacteria protein. The purity of the final product was over 98%. The product could obviously suppress the secretion of IL-2 by EL-4 cells stimulated with IL-1β. CONCLUSION: The expression of hIL-1Ra gene with bioactivity in E.coli lays experimental foundation for further development and utilisation.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2004年第4期484-487,共4页 Chinese Journal of Cellular and Molecular Immunology
关键词 hIL-1Ra 克隆 大肠杆菌 IL-1Ra cloning E.coli
  • 相关文献

参考文献10

  • 1Dinarello CA. Interleukin-1 and Interleukin-1 Antagonism [J].Blood, 1991,77(8): 1627 - 1652.
  • 2Campion GV, Lebsack ME, Lookabaugh J. Dose-range and dose-frequency study of recombinant human Interleukin-1 receptor antagonist in patients with rheumatoid [J]. Arthritis Rheum, 1996, 39 (7):1092 - 1101.
  • 3Bresnihan B, Alvaro Gracia JM, Cobby M. Treatment of reheumatoid arthritis with recombinant human Interleukin-1 receptor antagonist [J]. Arthritis Rheum, 1998, 41(12): 2196 -2204.
  • 4Jiang Y, Genant HK, Watt I. A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human Interleukin-1 receptor antagonist [J]. Arthritis Rheum, 2000, 43(5): 1001-1009.
  • 5Bendele A, McAbee T, Sennello G. Efficacy of sustained blood levels of Interleukin-1 receptor antagonist in animal models with human clinical data[J]. Arthritis Rheum, 1999, 42(3): 498 -506.
  • 6Opal SM, Fisher CJ, Dhainaut JF. Confirmatory interleukin-1 receptor antagonist trail in severe sepsis: a phase Ⅲ, randomized, doubleblind, placebo-cortrolled, multicenter trail [J]. Crit Care Meb,1997, 25(7): 1115 -1124.
  • 7Stephen P, Ron J. Primary structure and functional expression form complementary DNA of a human Interleukin-1 receptor antagonist [J]. Nature, 1990, 343(25): 341 -346.
  • 8Matsushime H, Roussel MF. Cloning and expression of murine interleukin-1 receptor antagonist in macrophages stimulated by Colonystimulating factor 1 [J]. Blood, 1991,78(3): 616 -623.
  • 9王大东,李基业,王金惠,徐东刚,焦华波,李涛,邓群,王嘉玺,黎沾良.新型人白细胞介素-13在大肠杆菌中的表达及生物活性分析[J].细胞与分子免疫学杂志,2003,19(4):316-318. 被引量:3
  • 10孙卫民 王惠琴.细胞因子研究方法学[M].北京:人民卫生出版社,1997.367-384.

二级参考文献9

  • 1[1]de Waal Malefyt R, Figdor CG, Huijkens R, et al. Effects of IL-13 on phenotype, cytokine production and cytotoxic function of human monocyte. Comparison with IL- 4 and modulation by IFN-γ or IL-10 [J]. J Immunol, 2000, 158: 6370-6381.
  • 2[2]Kornmann M, Kleeff J, Debinski W, et al. pancreatic cancer cells express interkeukin-13 and- 4 receptors, and their growth is inhibited by pseudomonas exotoxin coupled to interleukin-13 and- 4[J]. Anticancer Res, 1999, 19: 125-131.
  • 3[3]Bochaer BS, Klunk DA, Sterbinsky SA, et al. Interleukin-13 selectively induces vascular dhesion molecule-1 (VCAM-1)expression in human endothelial cells[J]. J Immunol, 2000, 164: 799-803.
  • 4[4]de Vries JE, Zurawski G. Immunoregulatory properties of IL-13: Its potential role in atopic disease[J]. Int Arch Allergy Immunol, 1995, 106: 175-179.
  • 5[5]Minty A, Chalon P, Derocq JM, et al. Interleukin-13 is a now human lymphokine regulating inflammatory and immune responses[J]. Nature, 1993, 362(58): 248-250.
  • 6[6]Wang G. High-level expression of prochymosin in Escherichia coli: effect of the secondary structure of the ribosome binding site[J]. Protein Expr Purif, 1995, 6(3): 284-290.
  • 7[7]Thill GP, Davis GR, Stillman C. Positive and negative effects of multi-copy integrated expression vectors on protein expression in Pichia pastoris. Proceedings of the 6th International Symposium on Genetics of Microorganism[C]. Paris: Societe Franscaise de Microbiologie, 1990, 2:477- 490.
  • 8[8]Rudolph R. In vitro folding of inclusion body protein[J]. FASEB J, 1996, 10(1): 49-56.
  • 9[9]Mckenzie AN, Culpepper JA, de Waal Malefyt R, et al. Interkin-13, a T-cell-derived cytokine that regulates human monocyte and B-cell function [J]. Prol Natl Acad Sci USA, 1993, 90:3735-3739.

共引文献7

同被引文献2

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部